b-cell lymphoma recurrent Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Loyola University (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadlymphoma

I am/have/hadhepatitis b

I am/have/hadb-cell lymphoma recurrent

I am/have/hadleukemia

I am/have/hadimmunodeficiency

I am/have/hadhepatitis c

I am/have/hadprimary immune deficiency disorder

I am/have/hadanticoagulation therapy

I am/have/hadimmediate hypersensitivity reaction

I am/have/hadsystemic disease

I am/have/hadrecurrent disease

I am/have/hadangina pectoris

I am/have/hadapheresis

I am/have/hadb-cell lymphoma refractory

I am/have/hadmeasurable disease

I am/have/hadabsolute lymphocyte count

I am/have/hadheart disease

I am/have/hadb-cell adult acute lymphoblastic leukemia

I am/have/hadblood transfusion

I am/have/hadleukapheresis

added new label for I am/have/had

more

I am looking for

I am looking forcyclophosphamide

I am looking forfludarabine

I am looking forimmunosuppressive agents

I am looking forfilgrastim

I am looking forhepatitis b

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies

In this protocol, the investigators hypothesize that modifying the process of producing CAR+ T-cells can help to improve responses and reduce toxicities. Building on previous in vitro studies that have shown successful production of CAR+ T-cells using a new production approach, the investigators are now studying the ability to produce …

lymphoma

hepatitis b

b-cell lymphoma recurrent

leukemia

immunodeficiency

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.